Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
48.00    3.50 (7.87%)
Bid:
47.50
Ask:
48.50
Spread: 1.00 (2.105%)
Market Cap: £92.09m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Q3 2018 Update

10 Oct 2018 07:00

RNS Number : 4852D
Iofina PLC
10 October 2018
 
 

 

Iofina plc

("Iofina", the "Group", or the "Company")

(LSE AIM: IOF)

 

Q3 2018 Update

Record Quarterly Iodine Production Since Company Inception

 

Iofina, specialists in the exploration and production of iodine and halogen-based specialty chemical derivatives, today provides an update to the market regarding its activities during the third quarter ("Q3" or the "Period") of 2018.

 

During the Period, the Company produced the largest quarterly total of crystalline iodine in the history of the organisation, producing a total of 172.3 metric tonnes ("MT") of crystalline iodine from its four operating IOsorb® plants in Oklahoma. This was an increase of 37.8 per cent from the prior year (Q3 2017: 125 MT). This record production reflected a full quarter of strong performance at the new IO#7 plant, as well as continued consistent operation of our mature IOsorb® plants.

 

The Directors anticipate that this positive momentum will continue as the Company moves into the fourth quarter and the winter months. The Directors also remain confident that the Company will achieve the 2018 forecast total of 575-605 MT of crystalline iodine. Iofina's current total of 436.4 MT of produced crystalline iodine through September positions the Company well to significantly surpass 2017 totals (FY 2017: 503 MT). 

 

Commenting, President and CEO Dr. Tom Becker, stated: 

"I am proud of the record quarterly production that has been achieved in the history of Iofina, in the third quarter this year. The execution of the Company's growth strategy, in particular the advantageous location of IO#7, and the performance of the operations team, continues to pay off for the Company and its stakeholders.

 

"Iofina Chemical continues to trade well and is exploring additional revenue streams. Not only have we been marketing the Company's IOflo® crystalline iodine, but also its other chemical products.

 

"As recently stated in our interim results, announced on 20th September 2018, production and profitability continue to move in a positive direction. Debt restructure and growth in 2019 remain the top priority for myself and the management team as we move towards the end of 2018. We expect the positive momentum we are currently achieving to significantly increase the Group's revenues and profits versus the first half of this year."

 

Enquiries:

 

Iofina plc

Dr. Tom Becker, CEO & President

Tel: +44 (0)20 3006 3135

www.iofina.com

 

finnCap Ltd

Christopher Raggett/Anthony Adams/Camille Gochez

Tel: +44 (0)20 7220 0500

 

Media Contact:

Yellow Jersey

Charles Goodwin/Harriet Jackson

Tel: +44 (0)7544 275 882

 About Iofina:

Iofina specialises in the exploration and production of iodine, halogen based specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America, based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Kentucky and Oklahoma. It is a vertically integrated company, covering the process from the production of iodine in the field, to the manufacture of the chemical end-products derived from iodine, supplying them to the consumer, and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilises its portfolio of patented and patent-pending technology, and proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDDKLFBVBFLFBV
Date   Source Headline
22nd Dec 20147:00 amRNSMarket update
16th Dec 20147:00 amRNSBoard Change
8th Dec 20147:00 amRNSExercise of Options and Total Voting Rights
28th Nov 20144:35 pmRNSPrice Monitoring Extension
17th Nov 20147:00 amRNSIssue of Patent and Market Update
30th Oct 20147:00 amRNSExercise of Options and Total Voting Rights
15th Oct 20147:00 amRNSTotal Voting Rights
10th Oct 20142:56 pmRNSTR-1: Notification of Major Interest in Shares
8th Oct 20149:15 amRNSTR-1: Notification of Major Interest in Shares
6th Oct 20147:00 amRNSProduction & Water Permit Update
30th Sep 20147:00 amRNSInterim Results
18th Sep 20147:00 amRNSProduction Update
5th Sep 20147:00 amRNSAppointment of CEO
14th Aug 20147:00 amRNSJuly Production Update
9th Jul 20147:00 amRNSJune Production Update
18th Jun 20147:00 amRNSExercise of Options and Total Voting Rights
10th Jun 20143:42 pmRNSResult of AGM & Appointment of Directors
3rd Jun 20147:00 amRNSIodine Production Update
16th May 20141:58 pmRNSNotice of AGM
6th May 20147:01 amRNSApril Iodine Production Update
29th Apr 20147:00 amRNSSuccessful Completion of Convertible Bond
28th Apr 20147:00 amRNSBoard Changes
25th Apr 20147:00 amRNSFinal Results
23rd Apr 20147:00 amRNSProduction Update
22nd Apr 20147:01 amRNSWater Project Update
15th Apr 20144:40 pmRNSAppointment of Director (amended)
14th Apr 20147:00 amRNSProduction Update
10th Apr 20148:03 amRNSAppointment of Director
7th Apr 20147:00 amRNSHolding(s) in Company
2nd Apr 20144:39 pmRNSHolding(s) in Company
27th Mar 20147:00 amRNSMarket update
20th Mar 20147:00 amRNSResignation and appointment of Director
7th Mar 20147:00 amRNSAmendment to the terms of Convertible Bond
28th Feb 20147:01 amRNSIO#4 and IO#5 Update
3rd Feb 20147:00 amRNSNon-Core Water Project Update
29th Jan 20147:00 amRNSOperational Update
28th Jan 20147:00 amRNSHolding(s) in Company
13th Jan 20147:00 amRNSChange of Adviser
6th Jan 201410:12 amRNSDirector Transfer of Shares
23rd Dec 20137:00 amRNSWater Project Update
17th Dec 20133:35 pmRNSDirector Dealing
17th Dec 201310:27 amRNSDirector Dealing
17th Dec 20137:00 amRNS2013 Review and 2014 Outlook
13th Dec 20132:55 pmRNSWater Permit
29th Nov 20137:00 amRNSDirectors' Disclosure
22nd Nov 20137:00 amRNSBoard Change
20th Nov 20137:00 amRNSOperational Update
12th Nov 20137:01 amRNSGrant of Options to Directors
5th Nov 20131:45 pmRNSChange of Registered Office
31st Oct 20137:00 amRNSCommissioning of IO#3 iodine extraction plant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.